ClinicalTrials.Veeva

Menu

Male Pelvic Floor Muscle Rehabilitation Exercises

D

Dream Video LLC

Status

Begins enrollment in 5 months

Conditions

Erectile Dysfunction
Premature Ejaculation
Urinary Incontinence

Treatments

Other: Male Pelvic Floor Rehabilitation #1

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Phase I

G128 Study Objective

The ischiocavernosus (IC) and bulbospongiosus (BS) muscles are vital components of the superficial perineal layer, serving as the foundation for male sexual health and performance. These muscles play a primary role in achieving and maintaining erections by compressing the veins to trap blood within the erectile tissues. Furthermore, they are responsible for the rhythmic contractions necessary for ejaculation and the physiological sensations associated with orgasm.

Beyond their role in sexual function, these muscles provide critical structural support to the pelvic floor and assist in urinary control. By working in tandem, the IC and BS muscles ensure penile rigidity while stabilizing the surrounding pelvic structures. Maintaining the strength and coordination of these muscles is essential for overall reproductive health and the prevention of pelvic floor dysfunction.

The primary objective of this clinical trial is to evaluate the clinical efficacy and therapeutic potential of Exercise G128 in strengthening the male pelvic floor musculature. Furthermore, the study aims to establish a comprehensive safety profile for Exercise G128 during active participation. The research seeks to address the following core investigative questions:

To what extent does Exercise G128 improve the tonicity and contractile strength of the IC and BS muscles?

What is the incidence and nature of adverse medical events or physiological stressors reported by participants while performing the Exercise G128 protocol?

Researchers will conduct a comparative analysis, benchmarking the physiological outcomes of Exercise G128 against existing clinical data regarding the efficacy of traditional Kegel exercises.

Participant Requirements:

Adhere to a structured regimen, performing Exercise G128 four times weekly over a one-month intervention period.

Attend bi-weekly telehealth consultations via video conferencing for supervised clinical assessments, progress monitoring, and physiological testing.

Maintain a detailed daily log documenting functional progress, as well as any instances of physical exertion or soreness that necessitated a temporary cessation of the exercise protocol.

Full description

G128 Study Objective

The primary purpose of this clinical investigation is to evaluate the physiological efficacy of the targeted G128 exercise protocol in enhancing the structural integrity and contractile strength of the pelvic floor musculature. This study specifically aims to measure hypertrophy and functional improvements within the Ischiocavernosus and Bulbospongiosus muscles following a standardized training period. By establishing these metrics, the research seeks to validate the protocol's impact on core pelvic stability.

Utilizing quantitative assessment tools, this research will determine whether the G128 regimen yields a statistically significant increase in pelvic muscle tone and endurance compared to baseline measurements. The findings may support the implementation of this regimen as a viable, non-invasive therapeutic intervention for patients experiencing various forms of pelvic floor dysfunction. Ultimately, the study strives to provide a data-driven foundation for advanced rehabilitative practices.

Enrollment

100 estimated patients

Sex

Male

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Men 18 - 75 years of age
  • Must be able to achieve an erection

Exclusion criteria

  • Underlying medical conditions or poor health
  • Men who fall within the obese category based on standard body mass index (BMI) measurements

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

G128 #1
Experimental group
Treatment:
Other: Male Pelvic Floor Rehabilitation #1

Trial contacts and locations

0

Loading...

Central trial contact

Matthew Quitto II

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems